Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003 - PubMed (original) (raw)
. 2004 Nov 5;53(43):1007-12.
- PMID: 15525897
Free article
Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2004.
Free article
Erratum in
- MMWR Morb Mortal Wkly Rep. 2005 Sep 23;54(37):935
Abstract
Vaccination of persons at risk for complications from influenza and pneumococcal disease is a key public health strategy for preventing associated morbidity and mortality in the United States. Risk factors include older age and medical conditions that increase the risk for complications from infections. During the 1990-1999 influenza seasons, more than 32,000 deaths each year among persons aged > or =65 years were attributed to complications from influenza infection. National health objectives for 2010 call for 90% influenza and pneumococcal vaccination coverage among noninstitutionalized persons aged > or =65 years and 60% coverage among noninstitutionalized persons aged 18-64 years who have risk factors (e.g., diabetes or asthma) for complications from infections. To estimate influenza and pneumococcal vaccination coverage among these populations, CDC analyzed data from the 2003 Behavioral Risk Factor Surveillance System (BRFSS) survey. This report summarizes the results of that analysis, which indicated that 1) influenza vaccination levels among adults aged 18-64 with diabetes or asthma, 2) pneumococcal vaccination levels among adults aged 18-64 years with diabetes, and 3) influenza and pneumococcal vaccination levels among adults aged > or =65 years all were below levels targeted in the national health objectives for 2010. Moreover, vaccination coverage levels varied among states for both vaccines and both age groups. Innovative approaches and adequate, reliable supplies of vaccine are needed to increase vaccination coverage, particularly among adults with high-risk conditions.
Similar articles
- Public health and aging: influenza vaccination coverage among adults aged > or =50 years and pneumococcal vaccination coverage among adults aged > or =65 years--United States, 2002.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2003 Oct 17;52(41):987-92. MMWR Morb Mortal Wkly Rep. 2003. PMID: 14561957 - Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years--United States, 2004-2005.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2006 Oct 6;55(39):1065-8. MMWR Morb Mortal Wkly Rep. 2006. PMID: 17021591 - Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1993.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1996 Oct 11;45(40):853-9. MMWR Morb Mortal Wkly Rep. 1996. PMID: 8927004 - Vaccines for persons at high risk, 2007.
Zimmerman RK, Middleton DB. Zimmerman RK, et al. J Fam Pract. 2007 Feb;56(2 Suppl Vaccines):S38-46, C4-5. J Fam Pract. 2007. PMID: 17270109 Review. - [Pneumococcal vaccination in adults].
Jonkers RE, Boersma WG. Jonkers RE, et al. Ned Tijdschr Geneeskd. 2003 Mar 8;147(10):437-41. Ned Tijdschr Geneeskd. 2003. PMID: 12666513 Review. Dutch.
Cited by
- Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review.
Mastrovito B, Lardon A, Dubromel A, Nave V, Beny K, Dussart C. Mastrovito B, et al. Front Public Health. 2024 Apr 19;12:1360556. doi: 10.3389/fpubh.2024.1360556. eCollection 2024. Front Public Health. 2024. PMID: 38706547 Free PMC article. Review. - Pneumococcal Vaccination Coverage and Uptake Among Adults in Switzerland: A Nationwide Cross-Sectional Study of Vaccination Records.
Zens KD, Baroutsou V, Fehr JS, Lang P. Zens KD, et al. Front Public Health. 2022 Jan 31;9:759602. doi: 10.3389/fpubh.2021.759602. eCollection 2021. Front Public Health. 2022. PMID: 35174130 Free PMC article. - Promising Expectations for Pneumococcal Vaccination during COVID-19.
Im H, Ser J, Sim U, Cho H. Im H, et al. Vaccines (Basel). 2021 Dec 20;9(12):1507. doi: 10.3390/vaccines9121507. Vaccines (Basel). 2021. PMID: 34960253 Free PMC article. Review. - Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals.
Almusalam YA, Ghorab MK, Alanezi SL. Almusalam YA, et al. J Family Med Prim Care. 2019 Jun;8(6):2112-2119. doi: 10.4103/jfmpc.jfmpc_265_19. J Family Med Prim Care. 2019. PMID: 31334189 Free PMC article. - Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis.
Badawi A, Ryoo SG. Badawi A, et al. J Public Health Res. 2016 Dec 21;5(3):733. doi: 10.4081/jphr.2016.733. eCollection 2016 Dec 9. J Public Health Res. 2016. PMID: 28083520 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous